1-7 of 7
Jason Cain
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 3029: Functional genomics pipeline reveals therapeutic dependencies in diffuse intrinsic pontine glioma

Sarah Parackal, Gabrielle Bradshaw, Claire Sun, Wai Chin Chong, Paul Daniel, Samantha Jayasekara, Duncan Crombie, Ron Firestein, Jason Cain, Department of Molecular Translational Science, Monash University
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): 3029.
https://doi.org/10.1158/1538-7445.AM2021-3029
Published: 01 July 2021
View article titled, Abstract 3029: Functional genomics pipeline reveals therapeutic dependencies in diffuse intrinsic pontine glioma
Journal Articles

Abstract 5771: Targeting EphA2 in bladder cancer using a novel antibody-directed nanotherapeutic

Walid Kamoun, Elden Swindell, Christine Pien, Lia Luus, Jason Cain, Irawati Kandela, Richard Huang, Suresh Tipparaju, Dmitri Kirpotin, Wiam Bshara, Vasileios Askoxylakis, Carl Morrison, Daryl Drummond
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 5771.
https://doi.org/10.1158/1538-7445.AM2018-5771
Published: 01 July 2018
View article titled, Abstract 5771: Targeting EphA2 in bladder cancer using a novel antibody-directed nanotherapeutic
Journal Articles

Preclinical Activity of Nanoliposomal Irinotecan Is Governed by Tumor Deposition and Intratumor Prodrug Conversion

Ashish V. Kalra, Jaeyeon Kim, Stephan G. Klinz, Nancy Paz, Jason Cain, Daryl C. Drummond, Ulrik B. Nielsen, Jonathan B. Fitzgerald
Journal: Cancer Research
Series: Author Choice
Cancer Res (2014) 74 (23): 7003–7013.
https://doi.org/10.1158/0008-5472.CAN-14-0572
Published: 30 November 2014
View article titled, Preclinical Activity of Nanoliposomal Irinotecan Is Governed by Tumor Deposition and Intratumor Prodrug Conversion
Open the PDF for Preclinical Activity of Nanoliposomal Irinotecan Is Governed by Tumor Deposition and Intratumor Prodrug Conversion in another window
Includes: Supplementary data
Journal Articles

Abstract 2065: Magnetic resonance imaging with an iron oxide nanoparticle demonstrates the preclinical feasibility of predicting intratumoral uptake and activity of MM-398, a nanoliposomal irinotecan (nal-IRI)

Ashish V. Kalra, Joseph Spernyak, Jaeyeon Kim, Arnold Sengooba, Stephan Klinz, Nancy Paz, Jason Cain, Walid Kamoun, Ninfa Straubinger, Yang Qu, Sheryl Trueman, Eliel Bayever, Ulrik Nielsen, Daryl Drummond, Jonathan Fitzgerald, Robert Straubinger
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 2065.
https://doi.org/10.1158/1538-7445.AM2014-2065
Published: 01 October 2014
View article titled, Abstract 2065: Magnetic resonance imaging with an iron oxide nanoparticle demonstrates the preclinical feasibility of predicting intratumoral uptake and activity of MM-398, a nanoliposomal irinotecan (nal-IRI)
Journal Articles

Abstract 76: Liver receptor homologue-1 increases incidence of DMBA-induced mammary tumors

Kyren A. Lazarus, Kristy Brown, Morag Young, Jason Cain, Samantha Jayasekara, Rhiannon Coulson, Neil Watkins, Colin Clyne, Ashwini Chand
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 76.
https://doi.org/10.1158/1538-7445.AM2014-76
Published: 01 October 2014
View article titled, Abstract 76: Liver receptor homologue-1 increases incidence of DMBA-induced mammary tumors
Journal Articles

Abstract 387: Activating transcription factor 3 (ATF-3) expression is a potential marker of tumor response to the HDAC inhibitor Pracinostat

Dhanya Sooraj, Dakang Xu, Jason Cain, Daniel Gold, Bryan R. Williams
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 387.
https://doi.org/10.1158/1538-7445.AM2014-387
Published: 01 October 2014
View article titled, Abstract 387: Activating transcription factor 3 (ATF-3) expression is a potential marker of tumor response to the HDAC inhibitor Pracinostat
Journal Articles

Abstract 2389: A microfluidic system for the selection of circulating tumor cells that utilizes both affinity and size capture technologies

Denis Smirnov, Keith Merdek, Kam Sprott, Alison Skelley, Richard Huang, Don Tenney, Chunsheng Jiang, Aladin Milutinovic, David Tims, Yi Dong, Jason Cain, Michele Wolfe, Bill Pierceall, Walter Carney
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 2389.
https://doi.org/10.1158/1538-7445.AM2012-2389
Published: 15 April 2012
View article titled, Abstract 2389: A microfluidic system for the selection of circulating tumor cells that utilizes both affinity and size capture technologies